The Effect of Continuous Glucose Monitoring in Individuals With Newly Diagnosed Type 2 Diabetes

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 250 participants.

Also called NCT06471699

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose supportive care
Phase
Not applicable
Enrolled
  • 250 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06471699
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06471699. Randomized; no masking; primary purpose supportive care. Start 2024-11-01 (anticipated); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of Continuous Glucose Monitoring in Individuals With Newly Diagnosed Type 2 Diabetes
Acronym
CHANGE-diab
Condition
Diabetes Type 2
Intervention (Device)
Continous Glucose Monitoring
Intervention (Other)
Self monitoring blood glucose
Lead sponsor
Vastra Gotaland Region (class: other government)
Collaborator
The Swedish Research Council (class: other government)
Collaborator
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct06471699
Content hash
d2070245df261d9167a9ddac83a1422c39373dc3f81e278d54a15ef07e0f7a8d